Tonix Pharmaceuticals Files 8-K
Ticker: TNXP · Form: 8-K · Filed: May 14, 2025 · CIK: 1430306
Sentiment: neutral
Topics: corporate-filing, regulation-fd, financials
Related Tickers: TNXP
TL;DR
TONX filed an 8-K on May 14, 2025, covering Reg FD, other events, and financials.
AI Summary
Tonix Pharmaceuticals Holding Corp. filed an 8-K on May 14, 2025, reporting on various events. The filing includes information related to Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The company, incorporated in Nevada, has its principal executive offices in Chatham, New Jersey.
Why It Matters
This 8-K filing provides updates on Tonix Pharmaceuticals' corporate activities and financial reporting, which are important for investors to monitor the company's status.
Risk Assessment
Risk Level: low — This filing is a routine corporate disclosure and does not appear to contain significant new risks.
Key Players & Entities
- Tonix Pharmaceuticals Holding Corp. (company) — Registrant
- May 14, 2025 (date) — Filing Date
- Nevada (jurisdiction) — State of Incorporation
- Chatham, New Jersey (location) — Principal Executive Offices
- 26 Main Street, Suite 101 (address) — Business Address
FAQ
What is the primary purpose of this 8-K filing for Tonix Pharmaceuticals Holding Corp.?
The primary purpose is to report on Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits as of May 14, 2025.
When was Tonix Pharmaceuticals Holding Corp. incorporated, and where are its principal executive offices located?
Tonix Pharmaceuticals Holding Corp. was incorporated in Nevada and its principal executive offices are located at 26 Main Street, Chatham, New Jersey.
What is the IRS Employer Identification Number (EIN) for Tonix Pharmaceuticals Holding Corp.?
The IRS Employer Identification Number (EIN) for Tonix Pharmaceuticals Holding Corp. is 26-1434750.
What is the SIC code for Tonix Pharmaceuticals Holding Corp.?
The Standard Industrial Classification (SIC) code for Tonix Pharmaceuticals Holding Corp. is 2834, which corresponds to Pharmaceutical Preparations.
What was the former name of Tonix Pharmaceuticals Holding Corp. and when did the name change occur?
The former name of Tonix Pharmaceuticals Holding Corp. was TAMANDARE EXPLORATIONS INC., and the date of the name change was March 20, 2008.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 14, 2025 regarding Tonix Pharmaceuticals Holding Corp. (TNXP).